1. Macdiarmid SA, Sand PK. Diagnosis of interstitial cystitis/ painful bladder syndrome in patients with overactive bladder symptoms. Rev Urol 2007;9:9-16. PMID:
17396167
2. Edmondson SD, Zhu C, Kar NF, Di Salvo J, Nagabukuro H, SacreSalem B, et al. Discovery of vibegron: a potent and selective β3 adrenergic receptor agonist for the treatment of overactive bladder. J Med Chem 2016;59:609-23. PMID:
26709102
4. Rovner ES, Wein AJ. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol 2002;41:6-14. PMID:
11999467
5. Diokno AC, Appell RA, Sand PK, Dmochowski RR, Gburek BM, Klimberg IW, et al. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc 2003;78:687-95. PMID:
12934777
6. Lose G, Norgaard JP. Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor. BJU Int 2001;87:767-73. PMID:
11412211
7. Chuang YC, Lee WC, Lee WC, Chiang PH. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol 2009;182:1393-400. PMID:
19683290
8. Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005;65:45-8. PMID:
15667861
9. Oosterlinck W, Kurth KH, Schroder F, Bultinck J, Hammond B, Sylvester R. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol 1993;149:749-52. PMID:
8455236
10. Nickel JC, Moldwin R, Lee S, Davis EL, Henry RA, Wyllie MG. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 2009;103:910-8. PMID:
19021619
11. Lazzeri M, Spinelli M, Beneforti P, Malaguti S, Giardiello G, Turini D. Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot study. Eur Urol 2004;45:98-102. PMID:
14667524
12. Fraser MO, Lavelle JP, Sacks MS, Chancellor MB. The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy. Rev Urol 2002;4:1-11. PMID:
16985646
14. Lee H, Cima MJ. An intravesical device for the sustained delivery of lidocaine to the bladder. J Control Release 2011;149:133-9. PMID:
20971144
15. Nickel JC, Jain P, Shore N, Anderson J, Giesing D, Lee H, et al. Continuous intravesical lidocaine treatment for interstitial cystitis/ bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med 2012;4:143ra100.
16. Wan LS, Hsu YC, Ganguly M, Bigelow B. Effects of the Progestasert on the menstrual pattern, ovarian steroids and endometrium. Contraception 1977;16:417-34. PMID:
923252
17. Zhou L, Harrison-Woolrych M, Coulter DM. Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Saf 2003;12:371-7. PMID:
12899110
18. Kleiner LW, Wright JC, Wang Y. Evolution of implantable and insertable drug delivery systems. J Control Release 2014;181:1-10. PMID:
24548479
19. Wright JC, Tao Leonard S, Stevenson CL, Beck JC, Chen G, Jao RM, et al. An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer. J Control Release 2001;75:1-10. PMID:
11451492
20. Herrlich S, Spieth S, Messner S, Zengerle R. Osmotic micropumps for drug delivery. Adv Drug Deliv Rev 2012;64:1617-27. PMID:
22370615
21. Rastogi A, Bowman PD, Stavchansky S. Evaluation of a perforated drug delivery system in mice for prolonged and constant release of a hydrophilic drug. Drug Deliv Transl Res 2012;2:106-11. PMID:
25786719
22. Park M, Park CG, Lee SH, Lee JE, Cho E, Prausnitz MR, et al. Polymeric tube-shaped devices with controlled geometry for programmed drug delivery. Macromol Res 2012;20:960-7.